These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7762503

  • 1. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators.
    Benedict CR, Francis GS, Shelton B, Johnstone DE, Kubo SH, Kirlin P, Nicklas J, Liang CS, Konstam MA, Greenberg B.
    Am J Cardiol; 1995 Jun 01; 75(16):1151-7. PubMed ID: 7762503
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
    Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S.
    Circulation; 1996 Aug 15; 94(4):690-7. PubMed ID: 8772689
    [Abstract] [Full Text] [Related]

  • 3. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.
    Benedict CR, Weiner DH, Johnstone DE, Bourassa MG, Ghali JK, Nicklas J, Kirlin P, Greenberg B, Quinones MA, Yusuf S.
    J Am Coll Cardiol; 1993 Oct 15; 22(4 Suppl A):146A-153A. PubMed ID: 8376686
    [Abstract] [Full Text] [Related]

  • 4. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD, Kronenberg MW, Benedict CR, Udelson JE, Kinan D, Stewart D, Yusuf S, Smith JJ, Kilcoyne L, Dolan N, Edens TR, Metherall J, Konstam MA.
    Am Heart J; 1997 Jul 15; 134(1):37-43. PubMed ID: 9266781
    [Abstract] [Full Text] [Related]

  • 5. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1993 Nov 15; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
    Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B.
    Circulation; 1995 May 15; 91(10):2573-81. PubMed ID: 7743619
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

  • 8. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
    Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI.
    Lancet; 2003 May 31; 361(9372):1843-8. PubMed ID: 12788569
    [Abstract] [Full Text] [Related]

  • 9. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S.
    Eur J Heart Fail; 2014 Mar 31; 16(3):325-33. PubMed ID: 24464788
    [Abstract] [Full Text] [Related]

  • 10. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
    Sigurdsson A, Eriksson SV, Hall C, Kahan T, Swedberg K.
    Eur J Heart Fail; 2001 Jan 31; 3(1):69-78. PubMed ID: 11163738
    [Abstract] [Full Text] [Related]

  • 11. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A.
    Circulation; 2003 Jun 17; 107(23):2926-31. PubMed ID: 12771010
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
    Rouleau JL, Packer M, Moyé L, de Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F.
    J Am Coll Cardiol; 1994 Sep 17; 24(3):583-91. PubMed ID: 7915733
    [Abstract] [Full Text] [Related]

  • 13. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.
    Rogers WJ, Johnstone DE, Yusuf S, Weiner DH, Gallagher P, Bittner VA, Ahn S, Schron E, Shumaker SA, Sheffield LT.
    J Am Coll Cardiol; 1994 Feb 17; 23(2):393-400. PubMed ID: 8294693
    [Abstract] [Full Text] [Related]

  • 14. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Feb 17; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 15. Neurohumoral variability in left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction.
    Kirlin PC, Benedict C, Shelton BJ, Francis G, Nicklas J, Liang CS, Kubo S, Johnstone D, Probstfield J, Yusuf S.
    Am J Cardiol; 1995 Feb 15; 75(5):354-9. PubMed ID: 7856527
    [Abstract] [Full Text] [Related]

  • 16. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.
    Benedict CR, Johnstone DE, Weiner DH, Bourassa MG, Bittner V, Kay R, Kirlin P, Greenberg B, Kohn RM, Nicklas JM.
    J Am Coll Cardiol; 1994 May 15; 23(6):1410-20. PubMed ID: 7909822
    [Abstract] [Full Text] [Related]

  • 17. Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators.
    Pratt CM, Gardner M, Pepine C, Kohn R, Young JB, Greenberg B, Capone R, Kostis J, Henzlova M, Gosselin G.
    Am J Cardiol; 1995 Jun 15; 75(17):1244-9. PubMed ID: 7778548
    [Abstract] [Full Text] [Related]

  • 18. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
    Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S.
    Circulation; 1990 Nov 15; 82(5):1724-9. PubMed ID: 2146040
    [Abstract] [Full Text] [Related]

  • 19. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators.
    Pouleur H, Rousseau MF, van Eyll C, Stoleru L, Hayashida W, Udelson JA, Dolan N, Kinan D, Gallagher P, Ahn S.
    Circulation; 1993 Aug 15; 88(2):481-91. PubMed ID: 8101772
    [Abstract] [Full Text] [Related]

  • 20. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
    Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA.
    J Am Coll Cardiol; 1998 Feb 15; 31(2):419-25. PubMed ID: 9462588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.